Availability and use of essential medicines in China: Manufacturing, supply, and prescribing in Shandong and Gansu provinces

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Chen, Wen ^a   Tang, Shenglan ^b,c   Sun, Jing ^d   Ross Degnan, Dennis ^e   Wagner, Anita K ^e  

^a FUDAN UNIVERSITY   (China)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d 1 162 Tayuan Diplomatic Office Building   (China)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL DRUG; HERBACEOUS AGENT;

ADMINISTRATIVE PERSONNEL; ADULT; ARTICLE; CHINA; COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG USE; ECONOMICS; HEALTH CARE DELIVERY; HEALTH SERVICE; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; INTERVIEW; MEDICAL LITERATURE; PHARMACIST; PHARMACY; PRESCRIPTION; STATISTICS;

ADMINISTRATIVE PERSONNEL; ADULT; CHINA; COMMERCE; DATA COLLECTION; DRUG INDUSTRY; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; DRUGS, CHINESE HERBAL; DRUGS, ESSENTIAL; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES MISUSE; HUMANS; INTERVIEWS AS TOPIC; PHARMACIES; PHARMACISTS; PHARMACOPOEIAS AS TOPIC; PHARMACY SERVICE, HOSPITAL;

EID: 77954547058     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-211     Document Type: Article

References (21)

1. China National Health Accounts Report. China National Health Economics Institute, Beijing 2008
2. Pharmaceutical policies in OECD countries: Reconciling social and industrial goals. Paris. S Jacobzone, Labour Market and Social Policy 2004 Occasional Papers No. 40
3. The problems and causes of essential medicines production, distribution and use. L Ye W Chen X Ying B Liu S Hu, Chinese Health Resources 2008 11 51 53
4. Addressing government and market failures with payment incentives: hospital reimbursement reform in Hainan, China. W Yip K Eggleston, Social Science & Medicine 2004 58 267 277
5. Health service delivery in China: A literature review. K Eggleston L Li Q Meng M Lindelow A Wagstaff, Health Economics 2008 17 149 165 10.1002/hec.1306 17880024
6. Drug prescribing in rural health facilities in China: Implication for service quality and cost. S Zhan S Tang Y Guo G Bloom, Tropical Doctor 1998 28 42 48 9481197
7. 25 years of the WHO essential medicines lists: progress and challenges. R Laing B Waning A Gray N Ford E Hoen, Lancet 2003 361 1723 1729 10.1016/S0140-6736(03)13375-2 12767751
8. Essential Medicines: WHO model lists of essential medicines. WHO, http://www.who.int/medicines/publications/essentialmedicines/en/
9. Pharmaceutical policy in China. Q Sun MA Santoro QY Meng C Liu K Eggleston, Health Affairs 2008 27 1042 1050 10.1377/hlthaff.27.4.1042 18607039
10. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Q Meng G Cheng L Silver X Sun C Rehnberg G Tomson, Health Policy and Planning 2005 20 185 196 10.1093/heapol/czi018 15840634
11. Issues in drug pricing, reimbursement, and access in China with references to other Asia-Pacific region. Y Chen SO Schweitzer, Value in Health 2008 11 suppl 1 124 129 10.1111/j.1524-4733.2008.00376.x 18387056
12. How to investigate drug use in health facilities: selected drug use indicators. INRUD and WHO Action Programme on Essential Drugs, World Health Organization, Geneva 1993 DAP Research Series N°7. WHO/DAP/93.1
13. Using indicators to measure country pharmaceutical situation: Fact book on WHO level I and level II monitoring indicators (WHO/TCM/2006.2). WHO, World Health Organization, Geneva 2006
14. Medicines use in primary care in developing and transitional countries: Fact Book summarizing results from studies reported between 1990 and 2006. WHO Essential Medicines and Pharmaceutical Policies, Geneva; World Health Organization, Holloway K, Ivanovska V, Vialle-Valentin C, Johnson A, Lewis S, Wagner A, Ross-Degnan D, 2009 WHO/EMP/MAR/2009.3
15. China's growing biomedical industry. P Han, Biologicals 2009 37 169 172 10.1016/j.biologicals.2009.02.010 19427231
16. Shandong Bio-industry Development Plan (2008∼2012). Shandong Provincial Government, http://www.shandong.gov.cn/art/2008/5/22/art-956-1360. html
17. Reform of how health care is paid for in China: challenges and opportunities. S Hu S Tang Y Liu Y Zhao M-L Escobar D de Ferranti, Lancet 2008 372 1846 1853 10.1016/S0140-6736(08)61368-9 18930520
18. Association between health insurance and antibiotics prescribing in four counties in rural China. H Dong L Bogg C Rehnberg V Diwan, Health Policy 1999 48 29 45 10.1016/S0168-8510(99)00026-3 10539584
19. Analysis of the frequency and rationality of use of antibiotics in 571 patients. H Chen L Han X Yao B Ji, China Pharmacy 2003 14 159 161
20. Opinions on deepening health sector reform. Chinese Communist Party Central Committee and the State Council, http://www.gov.cn/jrzg/2009-04/06/ content-1278721.htm
21. National Essential Medicines List for Primary Health Institutions. Chinese Ministry of Health, http://www.gov.cn/gzdt/2009-08/18/content-1395524. htm